Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
- Conditions
- Hyperphosphatemia
- Registration Number
- NCT00567723
- Lead Sponsor
- Shire
- Brief Summary
Patients who have been treated with Fosrenol for a minimum of 12 consecutive weeks and are receiving dialysis will be followed for 5 years to compare mortality, bone fractures and incidence of selected morbidities to patients with no lanthanum exposure and to patients being treated for hyperphosphatemia with any marketed product.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2105
Test Group
- Signed informed consent
- Patient must have ESRD and be receiving dialysis
- Prior treatment with Fosrenol for a minimum of 12 consecutive weeks
- Primary payer of healthcare must be Medicare (patient must supply Medicare Claim Number)
- Patient must be 18 years of age or older
Test Group
- Patients that do not meet inclusion criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compare all-cause mortality and bone fractures among three groups of subjects with end stage renal disease (ESRD) 5 years
- Secondary Outcome Measures
Name Time Method Compare the incidence of selected morbidities among three groups of patients with ESRD 5 years
Trial Locations
- Locations (189)
Clinical Research Center, Inc.
🇺🇸Birmingham, Alabama, United States
Clinical Research Consultants
🇺🇸Hoover, Alabama, United States
University of South Alabama
🇺🇸Mobile, Alabama, United States
Montgomery Kidney Specialists
🇺🇸Montgomery, Alabama, United States
California Kidney Specialist
🇺🇸San Dimas, California, United States
Atlantic Avenue Medical Clinic
🇺🇸Cudahy, California, United States
East Bay-South Hayward Dialysis Center
🇺🇸Hayward, California, United States
Renal Research Center
🇺🇸Los Alamitos, California, United States
USC Kidney Center
🇺🇸Los Angeles, California, United States
Beverly Nephrology
🇺🇸Los Angeles, California, United States
Scroll for more (179 remaining)Clinical Research Center, Inc.🇺🇸Birmingham, Alabama, United States